Showing results (141-150 of 163) with videos related to
Sort By:
Pageof 17
Aging Cell|July 21, 2025
Skeletal Maturity and Age-Related Changes in Immune Cells and Circulatory Factors Impair Large-Scale Bone RegenerationLuciana Yamamoto de Almeida, Catharine Dietrich, Ashleigh S Hanner, et al.Biorxiv : the Preprint Server for Biology|June 25, 2020
Structural basis of a public antibody response to SARS-CoV-2Meng Yuan, Hejun Liu, Nicholas C Wu, et al.Science (New York, N.Y.)|July 15, 2020
Structural basis of a shared antibody response to SARS-CoV-2Meng Yuan, Hejun Liu, Nicholas C Wu, et al.Plos Pathogens|January 20, 2026
The receptor binding properties of H5Ny influenza A viruses have evolved to bind to avian-type mucin-like O-glycansJulia Weber, Niels L D Ponse, Xueyong Zhu, et al.Cell Host & Microbe|November 24, 2019
Influenza H7N9 Virus Neuraminidase-Specific Human Monoclonal Antibodies Inhibit Viral Egress and Protect from Lethal Influenza Infection in MiceIuliia M Gilchuk, Sandhya Bangaru, Pavlo Gilchuk, et al.EMBO Molecular Medicine|July 12, 2017
A single mutation in Taiwanese H6N1 influenza hemagglutinin switches binding to human-type receptorsRobert P de Vries, Netanel Tzarum, Wenjie Peng, et al.Cell Reports|June 13, 2019
N-Glycolylneuraminic Acid as a Receptor for Influenza A VirusesFrederik Broszeit, Netanel Tzarum, Xueyong Zhu, et al.Chinese Medical Journal|April 13, 2023
Individualized red-cell transfusion strategy for non-cardiac surgery in adults: a randomized controlled trialRen Liao, Jin Liu, Wei Zhang, et al.Proceedings of the National Academy of Sciences of the United States of America|June 29, 2022
A broad and potent neutralization epitope in SARS-related coronavirusesMeng Yuan, Xueyong Zhu, Wan-Ting He, et al.Biorxiv : the Preprint Server for Biology|March 22, 2022
A broad and potent neutralization epitope in SARS-related coronavirusesMeng Yuan, Xueyong Zhu, Wan-Ting He, et al.Pageof 17